What is Meiragtx Holdings Plc's earnings per share (EPS)?

Meiragtx Holdings Plc (MGTX) reported diluted earnings per share of $-1.42 for fiscal year 2025. This represents a 33.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Meiragtx Holdings Plc Financials

MGTX

Source SEC Filings (10-K/10-Q) Updated Mar 30, 2026 Currency USD FYE March

This page shows Meiragtx Holdings Plc (MGTX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality

0.41x

For every $1 of reported earnings, Meiragtx Holdings Plc generates $0.41 in operating cash flow (-$46.4M OCF vs -$114.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-8.7x

Meiragtx Holdings Plc earns $-8.7 in operating income for every $1 of interest expense (-$106.0M vs $12.2M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.4M

YoY-80.8%

5Y CAGR-16.3%

Meiragtx Holdings Plc generated $6.4M in revenue in fiscal year 2025. This represents a decrease of 80.8% from the prior year.

EBITDA

-$93.4M

YoY+41.9%

Meiragtx Holdings Plc's EBITDA was -$93.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 41.9% from the prior year.

Net Income

-$114.2M

YoY-458.7%

Meiragtx Holdings Plc reported -$114.2M in net income in fiscal year 2025. This represents a decrease of 458.7% from the prior year.

EPS (Diluted)

$-1.42

YoY+33.0%

Meiragtx Holdings Plc earned $-1.42 per diluted share (EPS) in fiscal year 2025. This represents an increase of 33.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$50.2M

YoY+54.1%

Meiragtx Holdings Plc generated -$50.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 54.1% from the prior year.

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

81M

YoY+3.9%

5Y CAGR+13.0%

Meiragtx Holdings Plc had 81M shares outstanding in fiscal year 2025. This represents an increase of 3.9% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

-1655.8%

YoY-1162.3pp

5Y CAGR-1253.8pp

Meiragtx Holdings Plc's operating margin was -1655.8% in fiscal year 2025, reflecting core business profitability. This is down 1162.3 percentage points from the prior year.

Net Margin

-1784.4%

YoY-1723.0pp

5Y CAGR-1411.8pp

Meiragtx Holdings Plc's net profit margin was -1784.4% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1723.0 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$129.6M

YoY+8.5%

5Y CAGR+30.8%

Meiragtx Holdings Plc invested $129.6M in research and development in fiscal year 2025. This represents an increase of 8.5% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$3.8M

YoY-22.8%

5Y CAGR-28.8%

Meiragtx Holdings Plc invested $3.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 22.8% from the prior year.

MGTX Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$6.4M-80.8%	$33.3M+137.4%	$14.0M-12.0%	$15.9M-57.8%	$37.7M+142.2%	$15.6M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$129.6M+8.5%	$119.5M+15.1%	$103.8M+21.1%	$85.7M+28.5%	$66.7M+96.7%	$33.9M
SG&A Expenses	$52.9M-2.4%	$54.2M+14.6%	$47.3M+1.6%	$46.5M+6.4%	$43.8M-1.0%	$44.2M
Operating Income	-$106.0M+35.5%	-$164.2M-19.8%	-$137.1M-17.8%	-$116.4M-59.9%	-$72.8M-16.3%	-$62.6M
Interest Expense	$12.2M-8.1%	$13.3M+0.2%	$13.2M+167.8%	$4.9M+1617.4%	$288K+107.2%	$139K
Income Tax	$0	$0	$0	N/A	$0	$0
Net Income	-$114.2M-458.7%	-$20.4M+75.7%	-$84.0M+35.2%	-$129.6M-62.9%	-$79.6M-37.2%	-$58.0M
EPS (Diluted)	$-1.42+33.0%	$-2.12-42.3%	$-1.49+48.1%	$-2.87-59.4%	$-1.80-16.9%	$-1.54

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$410K-88.9%	$3.7M	N/A	$21.4M+96.1%	$10.9M+3768.8%	$282K-59.5%	$697K-65.8%	$2.0M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$32.5M-2.9%	$33.5M+2.2%	$32.8M+36.7%	$24.0M-8.6%	$26.2M-24.9%	$34.9M+1.8%	$34.3M+1.9%	$33.7M
SG&A Expenses	$13.6M+10.6%	$12.3M+31.5%	$9.4M-45.2%	$17.1M+34.3%	$12.7M+13.0%	$11.3M-14.4%	$13.1M+8.4%	$12.1M
Operating Income	-$46.1M-2.8%	-$44.8M-7.7%	-$41.6M-32.1%	-$31.5M+21.4%	-$40.0M+12.8%	-$45.9M+1.8%	-$46.8M-6.9%	-$43.8M
Interest Expense	$3.1M+1.0%	$3.0M-0.3%	$3.0M-10.8%	$3.4M+1.6%	$3.4M+3.2%	$3.3M+0.1%	$3.3M-5.8%	$3.4M
Income Tax	N/A	N/A	$0	$0	$0	$0	$0	$0
Net Income	-$50.5M-30.2%	-$38.8M+3.0%	-$40.0M-145.5%	$88.0M+323.6%	-$39.3M+19.1%	-$48.6M-137.8%	-$20.4M-201.1%	$20.2M
EPS (Diluted)	$-0.62-29.2%	$-0.48+5.9%	$-0.51	N/A	$-0.55+27.6%	$-0.76-137.5%	$-0.32	N/A

MGTX Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	N/A	$269.8M-17.4%	$326.7M+2.7%	$318.2M-0.6%	$320.2M-12.0%	$363.7M
Current Assets	N/A	$123.5M-22.6%	$159.6M+3.4%	$154.3M-15.8%	$183.2M-32.8%	$272.6M
Cash & Equivalents	N/A	$103.7M-20.0%	$129.6M+12.2%	$115.5M-16.1%	$137.7M-34.3%	$209.5M
Inventory	N/A	$385K	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	$707K-93.0%	$10.1M-52.5%	$21.3M	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	N/A	$201.9M+7.1%	$188.6M-6.0%	$200.5M+48.8%	$134.8M+7.7%	$125.1M
Current Liabilities	N/A	$60.8M-9.4%	$67.1M-18.3%	$82.1M+20.5%	$68.1M+25.8%	$54.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	N/A	$67.8M-50.9%	$138.2M+17.4%	$117.7M-36.5%	$185.4M-22.3%	$238.6M
Retained Earnings	N/A	-$702.0M-26.7%	-$554.2M-17.9%	-$470.2M-38.1%	-$340.6M-30.5%	-$261.0M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$189.5M-4.7%	$198.7M-11.3%	$224.0M-17.0%	$269.8M-9.9%	$299.5M+12.3%	$266.7M-13.8%	$309.2M-5.4%	$326.7M
Current Assets	$34.2M-27.4%	$47.1M-41.1%	$79.9M-35.3%	$123.5M-11.2%	$139.0M+25.5%	$110.8M-25.8%	$149.3M-6.5%	$159.6M
Cash & Equivalents	$14.8M-53.9%	$32.2M-51.6%	$66.5M-35.8%	$103.7M-15.6%	$122.9M+22.9%	$100.0M-16.1%	$119.2M-8.0%	$129.6M
Inventory	N/A	$314K-48.3%	$607K+57.7%	$385K	N/A	N/A	N/A	N/A
Accounts Receivable	$2.8M+21.1%	$2.3M+215.9%	$734K+3.8%	$707K-78.4%	$3.3M+101.4%	$1.6M-85.1%	$10.9M+7.7%	$10.1M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$230.0M+17.5%	$195.8M+2.5%	$190.9M-5.5%	$201.9M-0.9%	$203.8M+9.2%	$186.6M-0.5%	$187.5M-0.6%	$188.6M
Current Liabilities	$152.9M+186.2%	$53.4M+2.0%	$52.4M-13.8%	$60.8M+2.3%	$59.4M+26.4%	$47.0M-1.1%	$47.5M-29.1%	$67.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$40.6M-1470.2%	$3.0M-91.1%	$33.1M-51.2%	$67.8M-29.2%	$95.7M+19.6%	$80.0M-34.3%	$121.7M-11.9%	$138.2M
Retained Earnings	-$831.3M-6.5%	-$780.8M-5.2%	-$742.0M-5.7%	-$702.0M-5.9%	-$662.6M-6.3%	-$623.3M-8.5%	-$574.7M-3.7%	-$554.2M

MGTX Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$46.4M+55.6%	-$104.5M+0.8%	-$105.4M-44.1%	-$73.1M-594.2%	-$10.5M+83.5%	-$64.0M
Capital Expenditures	$3.8M-22.8%	$5.0M-75.4%	$20.2M-55.1%	$45.0M-3.0%	$46.4M+121.5%	$20.9M
Free Cash Flow	-$50.2M+54.1%	-$109.5M+12.8%	-$125.5M-6.3%	-$118.1M-107.6%	-$56.9M+33.0%	-$84.9M
Investing Cash Flow	-$4.1M-117.5%	$23.5M-31.0%	$34.0M+175.7%	-$45.0M+27.1%	-$61.7M-66.7%	-$37.0M
Financing Cash Flow	$12.3M-77.5%	$54.5M-35.1%	$84.0M-11.7%	$95.2M+5473.8%	$1.7M-97.9%	$82.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$12.2M+72.2%	-$43.9M-19.3%	-$36.8M-58.2%	-$23.3M+7.0%	-$25.0M-28.6%	-$19.5M+47.0%	-$36.7M-152.6%	-$14.5M
Capital Expenditures	$610K-50.6%	$1.2M-27.8%	$1.7M+40.4%	$1.2M+66.8%	$730K-45.1%	$1.3M-20.8%	$1.7M-44.6%	$3.0M
Free Cash Flow	-$12.8M+71.6%	-$45.2M-17.2%	-$38.5M-57.3%	-$24.5M+4.9%	-$25.8M-23.9%	-$20.8M+45.9%	-$38.4M-118.6%	-$17.6M
Investing Cash Flow	-$547K+28.1%	-$761K+55.5%	-$1.7M-40.4%	-$1.2M+7.3%	-$1.3M+1.1%	-$1.3M-104.9%	$27.3M-46.6%	$51.2M
Financing Cash Flow	-$219K-104.0%	$5.5M+218.2%	$1.7M-59.6%	$4.2M-91.5%	$50.0M+3016.5%	$1.6M+226.2%	-$1.3M-104.6%	$27.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

MGTX Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-1655.8%-1162.3pp	-493.4%+484.4pp	-977.8%-246.9pp	-730.9%-537.9pp	-193.0%+209.0pp	-401.9%
Net Margin	-1784.4%-1723.0pp	-61.4%+538.0pp	-599.5%+214.7pp	-814.2%-603.1pp	-211.0%+161.6pp	-372.6%
Return on Equity	N/A	-30.1%+30.7pp	-60.8%+49.3pp	-110.1%-67.2pp	-42.9%-18.6pp	-24.3%
Return on Assets	N/A	-7.6%+18.1pp	-25.7%+15.0pp	-40.7%-15.9pp	-24.9%-8.9pp	-16.0%
Current Ratio	N/A	2.03-0.3	2.38+0.5	1.88-0.8	2.69-2.3	5.03
Debt-to-Equity	N/A	2.98+1.6	1.36-0.3	1.70+1.0	0.73+0.2	0.52
FCF Margin	-784.1%-455.3pp	-328.9%+566.7pp	-895.6%-154.0pp	-741.6%-590.7pp	-150.9%+394.6pp	-545.5%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-11232.0%-10018.4pp	-1213.6%	N/A	-147.2%+219.8pp	-367.0%+15912.8pp	-16279.8%-9569.3pp	-6710.5%-4565.7pp	-2144.8%
Net Margin	-12320.2%-11269.2pp	-1051.1%	N/A	411.2%+771.7pp	-360.5%+16880.6pp	-17241.1%-14308.3pp	-2932.9%-3923.8pp	990.9%
Return on Equity	N/A	-1310.6%-1189.9pp	-120.8%-250.5pp	129.7%+170.8pp	-41.1%+19.7pp	-60.8%-44.0pp	-16.8%-31.4pp	14.6%
Return on Assets	-26.7%-7.1pp	-19.5%-1.7pp	-17.8%-50.4pp	32.6%+45.7pp	-13.1%+5.1pp	-18.2%-11.6pp	-6.6%-12.8pp	6.2%
Current Ratio	0.22-0.7	0.88-0.6	1.53-0.5	2.03-0.3	2.34-0.0	2.36-0.8	3.14+0.8	2.38
Debt-to-Equity	-5.67-71.8	66.13+60.4	5.77+2.8	2.98+0.8	2.13-0.2	2.33+0.8	1.54+0.2	1.36
FCF Margin	-3128.1%-1904.0pp	-1224.1%	N/A	-114.5%+121.5pp	-236.0%+7134.5pp	-7370.6%-1858.5pp	-5512.1%-4650.4pp	-861.6%

Similar Companies

Keros Therapeutics, Inc. KROS

$236.6M

Savara Inc SVRA

$1.1B

Oruka Therapeutics Inc ORKA

$2.6B

Nurix Therapeutics, Inc. NRIX

$1.6B

Rigel Pharmaceuticals Inc RIGL

$508.6M

Frequently Asked Questions

What is Meiragtx Holdings Plc's annual revenue?

Meiragtx Holdings Plc (MGTX) reported $6.4M in total revenue for fiscal year 2025. This represents a -80.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Meiragtx Holdings Plc's revenue growing?

Meiragtx Holdings Plc (MGTX) revenue declined by 80.8% year-over-year, from $33.3M to $6.4M in fiscal year 2025.

Is Meiragtx Holdings Plc profitable?

No, Meiragtx Holdings Plc (MGTX) reported a net income of -$114.2M in fiscal year 2025, with a net profit margin of -1784.4%.

What is Meiragtx Holdings Plc's EBITDA?

Meiragtx Holdings Plc (MGTX) had EBITDA of -$93.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Meiragtx Holdings Plc's operating margin?

Meiragtx Holdings Plc (MGTX) had an operating margin of -1655.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Meiragtx Holdings Plc's net profit margin?

Meiragtx Holdings Plc (MGTX) had a net profit margin of -1784.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Meiragtx Holdings Plc's free cash flow?

Meiragtx Holdings Plc (MGTX) generated -$50.2M in free cash flow during fiscal year 2025. This represents a 54.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Meiragtx Holdings Plc's operating cash flow?

Meiragtx Holdings Plc (MGTX) generated -$46.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Meiragtx Holdings Plc's capital expenditures?

Meiragtx Holdings Plc (MGTX) invested $3.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Meiragtx Holdings Plc spend on research and development?

Meiragtx Holdings Plc (MGTX) invested $129.6M in research and development during fiscal year 2025.

How many shares does Meiragtx Holdings Plc have outstanding?

Meiragtx Holdings Plc (MGTX) had 81M shares outstanding as of fiscal year 2025.

Are Meiragtx Holdings Plc's earnings high quality?

Meiragtx Holdings Plc (MGTX) has an earnings quality ratio of 0.41x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Meiragtx Holdings Plc cover its interest payments?

Meiragtx Holdings Plc (MGTX) has an interest coverage ratio of -8.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.